Concepedia

Karen Donaldson

KD

10

Publications

1.5K

Citations

10

H-Index

1994

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Karen Donaldson is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1994–2022

10

Publications

10

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

Alan F. Wahl, Karen Donaldson, Craig Faircnild et al. · Nature Medicine · 1996 · 661 citations

, , +9

Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle

Karen Donaldson, Gay Lynn Goolsby, Alan F. Wahl · International Journal of Cancer · 1994 · 195 citations

, , +15

Cyclin G1 and Cyclin G2 Comprise a New Family of Cyclins with Contrasting Tissue-specific and Cell Cycle-regulated Expression

Mary C. Horne, Gay Lynn Goolsby, Karen Donaldson et al. · Journal of Biological Chemistry · 1996 · 162 citations · Full text

Cyclin G2 Is Up-regulated during Growth Inhibition and B Cell Antigen Receptor-mediated Cell Cycle Arrest

Mary C. Horne, Karen Donaldson, Gay Lynn Goolsby et al. · Journal of Biological Chemistry · 1997 · 124 citations · Full text

Regulation of Inflammatory Responses by Oncostatin M

Philip M. Wallace, John F. MacMaster, Katherine A. Rouleau et al. · The Journal of Immunology · 1999 · 114 citations · Full text

, , +22

Rows per page

1–5 of 10